Obchod Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited - 0874 CFD
Pridať medzi obľúbené- Zhrnutie
- Historické dáta
- Udalosti
- Výkaz ziskov a strát
- Súvahový list
- Peňažný tok
- Vlastníctvo
Rozpätie | 0.45 | ||||||||
Nočný poplatok dlhej pozície
Long position overnight fee
Prejsť na platformu | -0.022785% | ||||||||
Nočný poplatok krátkej pozície
Short position overnight fee
Prejsť na platformu | 0.000868% | ||||||||
Nočný poplatok | 21:00 (UTC) | ||||||||
Minimálne množstvo na obchodovanie | 1 | ||||||||
Mena | HKD | ||||||||
Marža | 20% | ||||||||
Burza cenných papierov | Hong Kong | ||||||||
Provízia pri predaji | 0% |
*Information provided by Capital.com
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Predchádzajúce Zavrieť* | 25 |
Otvoriť* | 25.1 |
1-ročná zmena* | 13.83% |
Denný rozsah* | 24.95 - 25.5 |
Rozsah 52 týždňov | 16.56-27.70 |
Priemerný objem (10 dní) | 958.17K |
Priemerný objem (3 mesiace) | 22.63M |
Trhová kapitalizácia | 59.09B |
Pomer P/E | 9.12 |
Zdieľa mimoriadne | 1.63B |
Výnosy | 79.14B |
EPS | 2.76 |
Dividenda (udalosť %) | 3.23101 |
Beta | 0.70 |
Ďalší dátum zárobku | Aug 17, 2023 |
Všetky údaje poskytuje spoločnosť Refinitiv, okrem údajov označených hviezdičkou, čo sú *údaje poskytnuté Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zatvorenie | Change | Change (%) | Otvorenie | High | Low |
---|---|---|---|---|---|---|
Jun 2, 2023 | 25.20 | -0.15 | -0.59% | 25.35 | 25.50 | 25.05 |
Jun 1, 2023 | 25.00 | -0.80 | -3.10% | 25.80 | 25.85 | 24.95 |
May 31, 2023 | 25.95 | -0.45 | -1.70% | 26.40 | 26.50 | 25.80 |
May 30, 2023 | 26.35 | -0.10 | -0.38% | 26.45 | 26.75 | 26.05 |
May 29, 2023 | 26.35 | 0.25 | 0.96% | 26.10 | 27.45 | 26.10 |
May 25, 2023 | 24.50 | 0.05 | 0.20% | 24.45 | 24.65 | 24.15 |
May 24, 2023 | 24.50 | -0.80 | -3.16% | 25.30 | 25.30 | 24.45 |
May 23, 2023 | 25.55 | 0.10 | 0.39% | 25.45 | 25.90 | 25.45 |
May 22, 2023 | 25.50 | 0.15 | 0.59% | 25.35 | 26.05 | 25.35 |
May 19, 2023 | 25.40 | 0.30 | 1.20% | 25.10 | 25.70 | 25.10 |
May 18, 2023 | 25.50 | 0.20 | 0.79% | 25.30 | 25.95 | 25.20 |
May 17, 2023 | 25.30 | -0.05 | -0.20% | 25.35 | 25.60 | 25.30 |
May 16, 2023 | 25.70 | 0.60 | 2.39% | 25.10 | 26.00 | 25.10 |
May 15, 2023 | 25.40 | -0.25 | -0.97% | 25.65 | 25.80 | 24.80 |
May 12, 2023 | 25.85 | 0.25 | 0.98% | 25.60 | 26.00 | 25.60 |
May 11, 2023 | 25.80 | -0.70 | -2.64% | 26.50 | 26.60 | 25.80 |
May 10, 2023 | 26.40 | 0.40 | 1.54% | 26.00 | 26.40 | 25.90 |
May 9, 2023 | 26.30 | 0.15 | 0.57% | 26.15 | 26.65 | 25.90 |
May 8, 2023 | 26.45 | 1.00 | 3.93% | 25.45 | 26.70 | 25.45 |
May 5, 2023 | 25.45 | 0.45 | 1.80% | 25.00 | 25.75 | 25.00 |
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Events
Čas (UTC) (UTC) | Krajina | Udalosť |
---|---|---|
No events scheduled |
- Výročný
- Štvrťročne
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Celkové príjmy | 70788.2 | 69014.1 | 61673.7 | 64951.8 | 42233.8 |
Výnosy | 70788.2 | 69014.1 | 61673.7 | 64951.8 | 42233.8 |
Náklady na výnosy, celkom | 57516.1 | 55792.6 | 51257.3 | 52092.6 | 32224.6 |
Hrubý zisk | 13272.1 | 13221.4 | 10416.4 | 12859.1 | 10009.2 |
Celkové prevádzkové náklady | 65718 | 64231.2 | 58004.2 | 60899.2 | 38399 |
Predaj/Všeobecné/Správca. Náklady, Celkom | 7890.66 | 7903.36 | 6329.89 | 8361.46 | 6871.99 |
Výskum a vývoj | 777.95 | 837.424 | 577.059 | 543.369 | 558.362 |
Depreciation / Amortization | 587.366 | 528.648 | 498.554 | 443.573 | 213.317 |
Úrokové náklady (výnosy) – čistá prevádzka | -450.28 | -528.559 | -402.433 | -155.76 | -530.888 |
Other Operating Expenses, Total | -591.342 | -259.305 | -259.994 | -387.224 | -1057.67 |
Prevádzkový príjem | 5070.2 | 4782.84 | 3669.53 | 4052.58 | 3834.81 |
Gain (Loss) on Sale of Assets | |||||
Iné, Net | -26.9531 | -59.7689 | 69.5507 | 75.9566 | 183.919 |
Čistý príjem pred zdanením | 5043.24 | 4723.07 | 3739.08 | 4128.53 | 4018.73 |
Čistý príjem po zdanení | 4253.37 | 3968.99 | 3091.63 | 3441.29 | 3533.72 |
Menšinový záujem | -286.848 | -249.108 | -176.383 | -252.403 | -92.7361 |
Čistý príjem pred extra. Položky | 3966.52 | 3719.88 | 2915.24 | 3188.88 | 3440.98 |
Čistý príjem | 3966.52 | 3719.88 | 2915.24 | 3188.88 | 3440.98 |
Príjem k dispozícii bežnému Extra. Položky | 3966.52 | 3719.88 | 2915.24 | 3188.88 | 3440.98 |
Príjem k dispozícii bežnému vr. Extra. Položky | 3966.52 | 3719.88 | 2915.24 | 3188.88 | 3440.98 |
Zriedený čistý príjem | 3966.52 | 3719.88 | 2915.24 | 3188.88 | 3440.98 |
Zriedený vážený priemer akcií | 1625.79 | 1625.79 | 1625.79 | 1625.79 | 1625.79 |
Zriedený EPS s výnimkou mimoriadnych položiek | 2.43975 | 2.28804 | 1.79312 | 1.96144 | 2.1165 |
Dividends per Share - Common Stock Primary Issue | 0.424 | ||||
Zriedený normalizovaný EPS | 2.43328 | 2.26582 | 1.79507 | 1.96792 | 2.18103 |
Nezvyčajné výdavky (príjem) | -12.4733 | -42.9874 | 3.82206 | 1.13955 | 119.322 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Celkové príjmy | 21628.5 | 15982.2 | 17585.5 | 16681.9 | 20538.5 |
Výnosy | 21628.5 | 15982.2 | 17585.5 | 16681.9 | 20538.5 |
Náklady na výnosy, celkom | 16693.6 | 13613.8 | 14519.9 | 13871.7 | 15803.3 |
Hrubý zisk | 4934.89 | 2368.49 | 3065.59 | 2810.21 | 4735.25 |
Celkové prevádzkové náklady | 19275.8 | 15369.1 | 16456.2 | 15612.8 | 18275.7 |
Predaj/Všeobecné/Správca. Náklady, Celkom | 2569.27 | 2047.28 | 1817.13 | 1853.04 | 2421.41 |
Výskum a vývoj | 179.39 | 155.068 | 223.067 | 202.439 | 238.88 |
Úrokové náklady (výnosy) – čistá prevádzka | -130.959 | -320.469 | -75.7328 | -11.5529 | -172.284 |
Nezvyčajné výdavky (príjem) | -0.36393 | 0.19216 | -0.32701 | -0.54634 | -0.00863 |
Other Operating Expenses, Total | -35.2074 | -126.687 | -27.8447 | -302.345 | -15.5625 |
Prevádzkový príjem | 2352.76 | 613.108 | 1129.3 | 1069.18 | 2262.82 |
Iné, Net | 2.22754 | -26.817 | -4.5779 | -0.72949 | 0.96882 |
Čistý príjem pred zdanením | 2354.99 | 586.291 | 1124.72 | 1068.45 | 2263.79 |
Čistý príjem po zdanení | 1969.05 | 568.638 | 935.801 | 857.386 | 1891.55 |
Menšinový záujem | -60.4545 | -76.4824 | -51.43 | -73.0305 | -85.9053 |
Čistý príjem pred extra. Položky | 1908.6 | 492.155 | 884.371 | 784.355 | 1805.64 |
Čistý príjem | 1908.6 | 492.155 | 884.371 | 784.355 | 1805.64 |
Príjem k dispozícii bežnému Extra. Položky | 1908.6 | 492.155 | 884.371 | 784.355 | 1805.64 |
Príjem k dispozícii bežnému vr. Extra. Položky | 1908.6 | 492.155 | 884.371 | 784.355 | 1805.64 |
Zriedený čistý príjem | 1908.6 | 492.155 | 884.371 | 784.355 | 1805.64 |
Zriedený vážený priemer akcií | 1625.72 | 1625.79 | 1625.79 | 1625.79 | 1625.79 |
Zriedený EPS s výnimkou mimoriadnych položiek | 1.174 | 0.30272 | 0.54396 | 0.48245 | 1.11062 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Zriedený normalizovaný EPS | 1.17381 | 0.30283 | 0.5438 | 0.48218 | 1.11062 |
- Výročný
- Štvrťročne
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Celkové aktíva | 57064.3 | 52810.6 | 47396.6 | 45982.2 | 43031.3 |
Hotovosť a krátkodobé investície | 22978.6 | 21013.4 | 17819.1 | 18511.1 | 17656.9 |
Cash | 20804.7 | 20946 | 17739 | 16830.5 | 15050.1 |
Hotovosť a ekvivalenty | 67.3176 | 26.1768 | 1639.12 | 1064.79 | |
Krátkodobé investície | 2173.89 | 0 | 54 | 41.4952 | 1542.04 |
Pohľadávky celkom, netto | 20652.4 | 19174.8 | 17015.3 | 17216.1 | 15228.7 |
Accounts Receivable - Trade, Net | 14857.6 | 12816.5 | 12389.7 | 12555 | 10872.5 |
Total Inventory | 10671.6 | 10437.7 | 9764.53 | 9490.04 | 9231.74 |
Prepaid Expenses | 915.591 | 794.173 | 1081.67 | 744.1 | 888.793 |
Other Current Assets, Total | 1846.19 | 1390.46 | 1716 | 20.8704 | 25.1713 |
Total Assets | 74665.3 | 66117.8 | 59760.1 | 56893.7 | 51482.2 |
Property/Plant/Equipment, Total - Net | 6570.12 | 5835.88 | 5260.4 | 4726.1 | 3646.05 |
Property/Plant/Equipment, Total - Gross | 11233.9 | 9994.76 | 9083.66 | 8145.45 | 6628.1 |
Accumulated Depreciation, Total | -4663.78 | -4158.88 | -3823.25 | -3419.34 | -2982.05 |
Goodwill, Net | 829.473 | 829.473 | 825.573 | 825.573 | 825.573 |
Intangibles, Net | 2825.77 | 2592.96 | 2450.32 | 2487.3 | 1013.35 |
Long Term Investments | 6103.66 | 3105.27 | 2963.83 | 2161.67 | 2299.88 |
Other Long Term Assets, Total | 1271.97 | 943.637 | 863.312 | 710.777 | 666.04 |
Total Current Liabilities | 37395.1 | 32253.9 | 29243.2 | 29377 | 26948.8 |
Accounts Payable | 11200.3 | 11287.2 | 10874.8 | 9698.95 | 9313.28 |
Accrued Expenses | 2660.45 | 1361.47 | 1083.4 | 1544.84 | 1406.38 |
Notes Payable/Short Term Debt | 12928.8 | 11905.5 | 11550.3 | 9851.43 | 8561.88 |
Other Current Liabilities, Total | 9898.82 | 7453.94 | 5498.64 | 8052.37 | 7463.2 |
Total Liabilities | 42600.2 | 37055.6 | 33615.2 | 32708.9 | 29797.3 |
Total Long Term Debt | 2185.05 | 1250.51 | 1059.37 | 551.495 | 521.738 |
Long Term Debt | 1639.2 | 752.812 | 497.55 | 4.5 | 413.554 |
Deferred Income Tax | 394.588 | 331.728 | 286.359 | 266.909 | 249.762 |
Minority Interest | 1572.73 | 2264.48 | 2060.42 | 1804.69 | 1458.82 |
Other Liabilities, Total | 1052.69 | 955.032 | 965.831 | 708.803 | 618.187 |
Total Equity | 32065.1 | 29062.2 | 26144.8 | 24184.8 | 21684.9 |
Common Stock | 1625.79 | 1625.79 | 1625.79 | 1625.79 | 1625.79 |
Additional Paid-In Capital | 10105.7 | 9956.95 | 9885.01 | 9865.08 | 9865.08 |
Retained Earnings (Accumulated Deficit) | 20346.5 | 17496.9 | 14651.7 | 12694.1 | 10194.5 |
Other Equity, Total | 2.75475 | -17.4764 | -17.6735 | -0.13896 | -0.47714 |
Total Liabilities & Shareholders’ Equity | 74665.3 | 66117.8 | 59760.1 | 56893.7 | 51482.2 |
Total Common Shares Outstanding | 1625.79 | 1625.79 | 1625.79 | 1625.79 | 1625.79 |
Current Port. of LT Debt/Capital Leases | 706.732 | 245.803 | 236.107 | 229.361 | 204.024 |
Capital Lease Obligations | 545.843 | 497.698 | 561.824 | 546.995 | 108.185 |
Unrealized Gain (Loss) | -15.6557 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Celkové aktíva | 55437.2 | 57064.3 | 52858.4 | 52489.3 | 53344.1 |
Hotovosť a krátkodobé investície | 20302.8 | 22978.6 | 21723.7 | 22306.1 | 23584 |
Hotovosť a ekvivalenty | |||||
Krátkodobé investície | 56.8727 | 2173.89 | 50.6686 | 1111.23 | 10 |
Pohľadávky celkom, netto | 23040.9 | 20652.4 | 20005.4 | 19969.6 | 19858.7 |
Accounts Receivable - Trade, Net | 15951.4 | 14857.6 | 15161.5 | 14489.9 | 13869.3 |
Total Inventory | 8945.1 | 10671.6 | 8439.79 | 8191.79 | 8731.13 |
Prepaid Expenses | 503.399 | 915.591 | 620.051 | 637.568 | 614.477 |
Other Current Assets, Total | 2644.94 | 1846.19 | 2069.55 | 1384.18 | 555.727 |
Total Assets | 73658.3 | 74665.3 | 69552.6 | 66800.6 | 67042.1 |
Property/Plant/Equipment, Total - Net | 6624.77 | 6570.12 | 6045.7 | 6132.95 | 5766.1 |
Goodwill, Net | 829.473 | 829.473 | 829.473 | 829.473 | 829.473 |
Intangibles, Net | 2822.48 | 2825.77 | 2562.35 | 2574.89 | 2582.41 |
Long Term Investments | 6655.58 | 6103.66 | 6082.15 | 3783.09 | 3372.68 |
Other Long Term Assets, Total | 1288.83 | 1271.97 | 1174.5 | 990.917 | 1147.32 |
Total Current Liabilities | 32889 | 37395.1 | 31987 | 30678 | 31191.4 |
Accounts Payable | 11090.4 | 11200.3 | 11718.2 | 10832 | 10330.8 |
Accrued Expenses | 987.005 | 2660.45 | 976.886 | 2301.31 | 871.847 |
Notes Payable/Short Term Debt | 12075.2 | 12928.8 | 11867.2 | 12078.5 | 12935.7 |
Current Port. of LT Debt/Capital Leases | 684.043 | 706.732 | 636.403 | 253.093 | 252.625 |
Other Current Liabilities, Total | 8052.3 | 9898.82 | 6788.32 | 5213.12 | 6800.42 |
Total Liabilities | 39690.5 | 42600.2 | 38123.8 | 36259.9 | 36175.4 |
Total Long Term Debt | 3716.26 | 2185.05 | 2228.35 | 1747.61 | 1247.67 |
Long Term Debt | 3136.58 | 1639.2 | 1751.9 | 1250.62 | 752.838 |
Capital Lease Obligations | 579.671 | 545.843 | 476.447 | 496.995 | 494.836 |
Deferred Income Tax | 402.904 | 394.588 | 353.265 | 350.954 | 344.474 |
Minority Interest | 1633.11 | 1572.73 | 2450.18 | 2418.12 | 2345.61 |
Other Liabilities, Total | 1049.22 | 1052.69 | 1104.98 | 1065.26 | 1046.16 |
Total Equity | 33967.8 | 32065.1 | 31428.8 | 30540.7 | 30866.7 |
Common Stock | 1625.79 | 1625.79 | 1625.79 | 1625.79 | 1625.79 |
Additional Paid-In Capital | 10105.7 | 10105.7 | 9957 | 9957 | 9956.95 |
Retained Earnings (Accumulated Deficit) | 22255.1 | 20346.5 | 19854.4 | 18970 | 19302.6 |
Other Equity, Total | -18.7811 | 2.75475 | -8.34349 | -4.59955 | -18.6003 |
Total Liabilities & Shareholders’ Equity | 73658.3 | 74665.3 | 69552.6 | 66800.6 | 67042.1 |
Total Common Shares Outstanding | 1625.79 | 1625.79 | 1625.79 | 1625.79 | 1625.79 |
Cash | 20245.9 | 20804.7 | 21673 | 21194.9 | 23574 |
Property/Plant/Equipment, Total - Gross | 11233.9 | 10498 | |||
Accumulated Depreciation, Total | -4663.78 | -4365.05 | |||
Unrealized Gain (Loss) | -15.6557 | -7.51165 |
- Výročný
- Štvrťročne
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Hotovosť z prevádzkovej činnosti | 6999.08 | 5673.5 | 585.185 | 5022.37 | 5216.89 |
Cash Taxes Paid | -2759.33 | -2873.35 | -2637.89 | -2998.66 | -2158.12 |
Zmeny pracovného kapitálu | 6999.08 | 5673.5 | 585.185 | 5022.37 | 5216.89 |
Peniaze z investičných činností | -7253.19 | -931.569 | -1088.06 | -1028.4 | 1109.72 |
Kapitálové výdavky | -1383.87 | -1254.92 | -876.503 | -2399.81 | -478.617 |
Ostatné investičné položky peňažných tokov, celkom | -5869.31 | 323.348 | -211.554 | 1371.42 | 1588.33 |
Hotovosť z finančných činností | 45.9498 | -1493.98 | 1439.38 | -2231.81 | -2751.34 |
Financovanie položiek peňažných tokov | -8.90345 | -396.831 | -29.9475 | -606.1 | -410.892 |
Total Cash Dividends Paid | -1490.54 | -1266.06 | -1289.91 | -1045.69 | -870.559 |
Vydanie (vyradenie) dlhu, netto | 1545.39 | 168.908 | 2759.24 | -580.025 | -1469.89 |
Devízové efekty | -0.50326 | 0.28283 | -4.99446 | -0.14847 | 0.80701 |
Čistá zmena v hotovosti | -208.665 | 3248.23 | 931.51 | 1762.01 | 3576.08 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Cash From Operating Activities | -2838.88 | 6999.08 | 3299.47 | 1712.21 | 918.064 |
Cash Taxes Paid | -1004.83 | -2759.33 | -2152.58 | -1459 | -816.54 |
Changes in Working Capital | -2838.88 | 6999.08 | 3299.47 | 1712.21 | 918.064 |
Cash From Investing Activities | -638.056 | -7253.19 | -5873.83 | -2630.43 | -429.199 |
Capital Expenditures | -234.832 | -1383.87 | -898.324 | -550.585 | -274.643 |
Other Investing Cash Flow Items, Total | -403.224 | -5869.31 | -4975.51 | -2079.84 | -154.556 |
Cash From Financing Activities | 1571.44 | 45.9498 | 1291.27 | 1094.51 | 848.638 |
Financing Cash Flow Items | 0.42527 | -8.90345 | 387.949 | 863.484 | -4.18243 |
Total Cash Dividends Paid | -89.6695 | -1490.54 | -1398.89 | -1140.22 | -88.0997 |
Issuance (Retirement) of Debt, Net | 1660.68 | 1545.39 | 2302.21 | 1371.25 | 940.92 |
Foreign Exchange Effects | 1.79747 | -0.50326 | -0.8763 | 5.22974 | -0.56164 |
Net Change in Cash | -1903.7 | -208.665 | -1283.97 | 181.526 | 1336.94 |
Meno investora | Typ investora | Percento vynikajúce | Držané akcie | Zmena akcií | Dátum držby | Hodnotenie obratu |
---|---|---|---|---|---|---|
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 16.0441 | 35281000 | 2248000 | 2023-05-24 | LOW |
LSV Asset Management | Investment Advisor | 6.0264 | 13252000 | 0 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.1477 | 6921712 | 0 | 2023-04-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.3397 | 2946000 | 8000 | 2023-04-30 | LOW |
China Merchants Fund Management Co. Ltd. | Investment Advisor | 1.2025 | 2644193 | 1840000 | 2022-06-30 | LOW |
Goldman Sachs Asset Management, L.P. | Investment Advisor | 0.7389 | 1624868 | 0 | 2023-04-30 | LOW |
MOS Capital | Investment Advisor/Hedge Fund | 0.3929 | 864000 | 864000 | 2022-12-31 | MED |
Goldman Sachs Asset Management International | Investment Advisor | 0.2492 | 548000 | 0 | 2023-03-31 | MED |
California Public Employees' Retirement System | Pension Fund | 0.1965 | 432000 | -50000 | 2022-06-30 | LOW |
Handelsbanken Kapitalförvaltning AB | Investment Advisor/Hedge Fund | 0.191 | 420000 | 0 | 2023-04-30 | LOW |
State Street Global Advisors (UK) Ltd. | Investment Advisor/Hedge Fund | 0.1901 | 418004 | 0 | 2023-04-30 | LOW |
Rheos Capital Works Inc. | Investment Advisor | 0.1715 | 377083 | -42930 | 2022-02-28 | LOW |
First Trust Advisors L.P. | Investment Advisor | 0.1386 | 304777 | 304777 | 2023-04-30 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.119 | 261728 | 0 | 2023-04-30 | LOW |
AXA Investment Managers UK Ltd. | Investment Advisor/Hedge Fund | 0.1119 | 246000 | 0 | 2023-04-30 | LOW |
Dimensional Fund Advisors, Ltd. | Investment Advisor | 0.1037 | 228000 | 0 | 2023-04-30 | LOW |
LähiTapiola Varainhoito Oy | Investment Advisor | 0.0937 | 206000 | 0 | 2022-03-31 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.091 | 200000 | 0 | 2023-04-30 | LOW |
Russell Investments Limited | Investment Advisor | 0.0809 | 178000 | 0 | 2023-04-30 | MED |
HAC VermögensManagement AG | Investment Advisor | 0.0782 | 172000 | -86000 | 2023-03-31 | MED |
Prečo si vybrať Capital.com? Naše čísla hovoria samy za seba.
Capital.com Group535K+
Obchodníci
87K+
Aktívni klienti za mesia
$113M+
Mesačný objem investícií
$64M+
Výbery každý mesiac
Obchodná kalkulačka
Vypočítajte si svoj hypotetický zisk a stratu, ak ste otvorili obchod s CFD v určitý deň (vyberte dátum) a uzavreli v iný dátum (vyberte dátum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Guangzhou Baiyunshan Pharma Company profile
O spoločnosti Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Spoločnosť Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd sa zaoberá farmaceutickým a zdravotníckym priemyslom. Segmenty spoločnosti sú Great Southern TCM, Great Commerce, Great Health a Great Medical Care. Veľká južná TCM spoločnosti zahŕňa výskum, vývoj, výrobu a predaj čínskych a západných liekov, chemických surovín, prírodných liečiv, biologických liekov a medziproduktov chemických surovín. Segment spoločnosti Great Health zahŕňa výskum, vývoj, výrobu a predaj nápojov, potravín, výrobkov pre zdravie a iných výrobkov. Segment Veľký obchod spoločnosti zahŕňa veľkoobchod, maloobchod, dovoz a vývoz západnej medicíny, čínskej medicíny a lekárskych prístrojov a nástrojov. Segment Great Medical sa zaoberá zdravotníckymi službami, tradičnou čínskou medicínou na zachovanie zdravia, moderným dôchodkovým priemyslom a zdravotníckym vybavením.
Industry: | Pharmaceuticals (NEC) |
荔湾区沙面北街45号
GUANGZHOU
GUANGDONG 510130
CN
Výkaz ziskov a strát
- Annual
- Quarterly
Ľudia tiež sledujú
Stále hľadáte brokera, ktorému sa dá veriť?
Pridajte sa k 535 000 obchodníkom na celom svete, ktorí sa rozhodli obchodovať s Capital.com